Innovative Lipid-Lowering Strategies: RNA-Based, Small Molecule, and Protein-Based Therapies

Dyslipidemia remains a central modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD). While 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly known as statins, as well as ezetimibe, fibrates, and omega-3 fatty acids have established roles in lipid low...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Youngwoo Jang, Eun-Jung Rhee, Sung Hee Choi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Endocrine Society 2025-10-01
coleção:	Endocrinology and Metabolism
Assuntos:	rna, small interfering angiopoietin-like protein 3 pcsk9 inhibitors apolipoprotein c-iii cholesterol ester transfer proteins lipoprotein(a)
Acesso em linha:	http://www.e-enm.org/upload/pdf/enm-2025-2691.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!